{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:49:18Z","timestamp":1791942558258,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-026-14336-1","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:03:42Z","timestamp":1774062222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A framework policy analysis of single-dose HPV vaccination adoption in East Africa: a rapid review"],"prefix":"10.1186","volume":"26","author":[{"given":"Grace","family":"Umutesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan J.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saidi","family":"Kapiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly R.","family":"Mugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruanne V.","family":"Barnabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"key":"14336_CR1","unstructured":"Cervical cancer [Internet]. https:\/\/www.who.int\/health-topics\/cervical-cancer. Available from. [cited 2024 Oct 17]."},{"key":"14336_CR2","unstructured":"World Health Organization. Immunization Data. WHO immunization data portal - detail page. Available from: https:\/\/immunizationdata.who.int\/global\/wiise-detail-page. cited 2024 Oct 17."},{"key":"14336_CR3","unstructured":"World Health Organization. Power BI report [internet]. https:\/\/app.powerbi.com\/view?r=eyJrIjoiNDIxZTFkZGUtMDQ1Ny00MDZkLThiZDktYWFlYTdkOGU2NDcwIiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9. Available from. [cited 2024 Oct 17]."},{"key":"14336_CR4","doi-asserted-by":"crossref","unstructured":"Human papillomavirus vaccines. Vaccine. 2014-Recommendations. October;33(36):4383\u201384. 2015 Aug 26: WHO position paper.","DOI":"10.1016\/j.vaccine.2014.12.002"},{"key":"14336_CR5","unstructured":"Human papillomavirus vaccines: WHO position paper, May 2017 [Internet]. https:\/\/www.who.int\/publications\/i\/item\/who-wer9219-241-268. Available from. [cited 2025 Jan 31]."},{"key":"14336_CR6","unstructured":"Human papillomavirus vaccines. WHO position paper. 2022 [Internet]. December. https:\/\/www.who.int\/publications\/i\/item\/who-wer9750-645-672. Available from.\u00a0[cited 2025 Jan 31]."},{"key":"14336_CR7","unstructured":"Cancer Today [Internet]. https:\/\/gco.iarc.who.int\/today\/. Available from. [cited 2024 Dec 3]."},{"key":"14336_CR8","unstructured":"International Agency for Research on Cancer. Eastern Africa fact sheet. Pdf [Internet]. https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/910-eastern-africa-fact-sheet.pdf. Available from. [cited 2025 Feb 3]."},{"key":"14336_CR9","unstructured":"International Agency for Research on Cancer. Ethiopia fact sheet. Pdf [Internet]. Available from: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/231-ethiopia-fact-sheet.pdf."},{"key":"14336_CR10","unstructured":"International Agency for Research on Cancer. Uganda fact sheet. Pdf [Internet]. https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/800-uganda-fact-sheet.pdf. Available from. [cited 2025 Feb 3]."},{"key":"14336_CR11","unstructured":"International Agency for Research on Cancer. Tanzania fact sheet. Pdf [Internet]. Available from: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/834-tanzania-united-republic-of-fact-sheet.pdf."},{"key":"14336_CR12","doi-asserted-by":"crossref","unstructured":"Watson-Jones D, Changalucha J, Whitworth H, Pinto L, Mutani P, Indangasi J, et al. Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial. Lancet Glob Health. 2022, Oct;10(10):e1473\u201384.","DOI":"10.1016\/S2214-109X(22)00309-6"},{"issue":"12","key":"14336_CR13","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1038\/s41591-023-02658-0","volume":"29","author":"RV Barnabas","year":"2023","unstructured":"Barnabas RV, Brown ER, Onono MA, Bukusi EA, Njoroge B, Winer RL, et al. Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results. Nat Med. 2023, Dec;29(12):3224\u201332.","journal-title":"Nat Med"},{"key":"14336_CR14","first-page":"100486","volume":"19","author":"HS Whitworth","year":"2024","unstructured":"Whitworth HS, Mounier-Jack S, Choi EM, Gallagher KE, Howard N, Kelly H, et al. Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: an updated systematic review of evidence from clinical trials. Vaccine. 2024, Apr, 16;19:100486.","journal-title":"Vaccine"},{"issue":"11","key":"14336_CR15","first-page":"1248","volume":"12","author":"G Umutesi","year":"2024","unstructured":"Umutesi G, Hathaway CL, Heitner J, Jackson R, Miano CW, Mugambi W, et al. The potential impact of a single dose HPV vaccination schedule on cervical cancer outcomes in Kenya: a mathematical modelling and Health economic analysis. Nato Adv Sci Inst Se. 2024, Nov;12(11):1248.","journal-title":"Nato Adv Sci Inst Se"},{"issue":"67","key":"14336_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/jncimonographs\/lgae037","volume":"2024","author":"R Slavkovsky","year":"2024","unstructured":"Slavkovsky R, Mvundura M, Debellut F, Naddumba T. Evaluating potential program cost savings with a single-dose HPV vaccination schedule: a modeling study. JNCI Monogr. 2024, Nov, 1;2024(67):371\u201378.","journal-title":"JNCI Monogr"},{"issue":"67","key":"14336_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/jncimonographs\/lgae031","volume":"2024","author":"G Umutesi","year":"2024","unstructured":"Umutesi G, Weiner BJ, Oluoch L, Bukusi E, Onono M, Njoroge B, et al. Acceptability of single-dose HPV vaccination schedule among health-care professionals in Kenya: a mixed-methods study. JNCI Monogr. 2024, Nov, 1;2024(67):358\u201370.","journal-title":"JNCI Monogr"},{"issue":"67","key":"14336_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/jncimonographs\/lgae041","volume":"2024","author":"S Delany-Moretlwe","year":"2024","unstructured":"Delany-Moretlwe S, Machalek DA, Travill D, Petoumenos K, Nyemba DC, Mbulawa ZZA, et al. Impact of single-dose HPV vaccination on HPV 16 and 18 prevalence in South African adolescent girls with and without HIV. JNCI Monogr. 2024, Nov, 1;2024(67):337\u201345.","journal-title":"JNCI Monogr"},{"key":"14336_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.socscimed.2015.10.001","volume":"145","author":"TW Valente","year":"2015","unstructured":"Valente TW, Dyal SR, Chu KH, Wipfli H, Fujimoto K. Diffusion of innovations theory applied to global tobacco control treaty ratification. Soc Sci Med. 2015, Nov, 1;145:89\u201397.","journal-title":"Soc. Sci. Med"},{"issue":"5","key":"14336_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/heapol\/czn019","volume":"23","author":"L Gilson","year":"2008","unstructured":"Gilson L, Raphaely N. The terrain of health policy analysis in low and middle income countries: a review of published literature 1994-2007. Health Policy Plan. 2008, Sept;23(5):294\u2013307.","journal-title":"Health Policy Plan"},{"issue":"4","key":"14336_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/heapol\/9.4.353","volume":"9","author":"G Walt","year":"1994","unstructured":"Walt G, Gilson L. Reforming the health sector in developing countries: the central role of policy analysis. Health Policy Plan. 1994;9(4):353\u201370.","journal-title":"Health Policy Plan"},{"key":"14336_CR22","first-page":"206 p","volume-title":"Making health policy","author":"K Buse","year":"2009","unstructured":"Buse K, Mays N, Walt G. Making health policy. Reprint. Maidenhead: Open Univ. Press; 2009. p. 206 p. (Understanding public health.","edition":"Reprint"},{"issue":"1","key":"14336_CR23","doi-asserted-by":"publisher","first-page":"1611243","DOI":"10.1080\/16549716.2019.1611243","volume":"12","author":"V Shiroya","year":"2019","unstructured":"Shiroya V, Neuhann F, M\u00fcller O, Deckert A. Challenges in policy reforms for non-communicable diseases: the case of diabetes in Kenya. Glob Health Action. 2019, Jan, 1;12(1):1611243.","journal-title":"Glob Health Action"},{"key":"14336_CR24","doi-asserted-by":"publisher","first-page":"1219676","DOI":"10.3389\/fpubh.2023.1219676","volume":"11","author":"D Tao","year":"2023","unstructured":"Tao D, Awan-Scully R, Ash GI, Gu Y, Pei Z, Gao Y, et al. Health policy considerations for combining exercise prescription into noncommunicable diseases treatment: a narrative literature review. Front Public Health. 2023;11:1219676.","journal-title":"Front Public Health"},{"key":"14336_CR25","doi-asserted-by":"publisher","first-page":"100016","DOI":"10.1016\/j.hpopen.2020.100016","volume":"1","author":"GL O\u2019Brien","year":"2020","unstructured":"O\u2019Brien GL, Sinnott SJ, Walshe V, Mulcahy M, Byrne S. Health policy triangle framework: narrative review of the recent literature. Health Policy (New Y) Open. 2020, Dec, 1;1:100016.","journal-title":"Health Policy (New Y) Open"},{"key":"14336_CR26","unstructured":"Covidence [Internet]. [Covidence - better systematic review management. Available from: https:\/\/www.covidence.org\/. cited 2024 Dec 16."},{"key":"14336_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jclinepi.2020.10.007","volume":"130","author":"C Garritty","year":"2021","unstructured":"Garritty C, Gartlehner G, Nussbaumer-Streit B, King VJ, Hamel C, Kamel C, et al. Cochrane rapid reviews methods group offers evidence-informed guidance to conduct rapid reviews. J Clin Epidemiol. 2021, Feb;130:13\u201322.","journal-title":"J Clin Epidemiol"},{"key":"14336_CR28","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA, 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, Mar, 29;372:n71.","DOI":"10.1136\/bmj.n71"},{"key":"14336_CR29","doi-asserted-by":"crossref","unstructured":"Mphuru A, Li AJ, Kyesi F, Mwengee W, Mazige F, Nshunju R, et al. National introduction of human papillomavirus (HPV) vaccine in Tanzania: programmatic decision-making and implementation. Vaccine. 2022, Mar31;40 Suppl 1(Suppl 1): A2\u20139.","DOI":"10.1016\/j.vaccine.2021.04.025"},{"key":"14336_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pvr.2018.10.004","volume":"6","author":"KE Gallagher","year":"2018","unstructured":"Gallagher KE, Kelly H, Cocks N, Dixon S, Mounier-Jack S, Howard N, et al. Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries. Papillomavirus Res Amst Neth. 2018, Dec;6:33\u201340.","journal-title":"Papillomavirus Res Amst Neth"},{"key":"14336_CR31","unstructured":"Gallagher K, Kelly H, Cocks N, Mounier-Jack S, Dixon S, Howard N, et al. Scoping views to a single dose human papillomavirus (HPV) vaccine schedule amongst vaccine policy makers in low and middle-income countries."},{"key":"14336_CR32","doi-asserted-by":"crossref","unstructured":"Li AJ, Kyesi F, Mwengee W, Mphuru A, Giattas MR, Shayo B, et al. Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania\u2019s national HPV vaccine introduction. Vaccine. 2022, Mar;40:A26\u20139.","DOI":"10.1016\/j.vaccine.2021.01.036"},{"key":"14336_CR33","unstructured":"PATH. HPV vaccination in Africa: lessons learned from a pilot program in Uganda. Available from: https:\/\/media.path.org\/documents\/RH_hpv_lessons_learned_uganda.pdf."},{"key":"14336_CR34","doi-asserted-by":"crossref","unstructured":"Gallagher KE, Howard N, Kabakama S, Mounier-Jack S, Griffiths UK, Feletto M, et al. Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries. PLoS One. 2017, June, 2;12(6):e0177773.","DOI":"10.1371\/journal.pone.0177773"},{"key":"14336_CR35","doi-asserted-by":"publisher","first-page":"106335","DOI":"10.1016\/j.ypmed.2020.106335","volume":"144","author":"VD Tsu","year":"2021","unstructured":"Tsu VD, LaMontagne DS, Atuhebwe P, Bloem PN, Ndiaye C. National implementation of HPV vaccination programs in low-resource countries: lessons, challenges, and future prospects. Prev Med. 2021, Mar;144:106335.","journal-title":"Prev Med"},{"key":"14336_CR36","unstructured":"World Health Organization. Ethiopia launchs a pilot human papilloma virus vaccination project | WHO | Regional Office for Africa [Internet]. 2025. Available from. https:\/\/www.afro.who.int\/news\/ethiopia-launchs-pilot-human-papilloma-virus-vaccination-project. [cited 2025 Jan 28]."},{"key":"14336_CR37","unstructured":"World Health Organization. The human papillomavirus (HPV) single-dose schedule elevated the total number of vaccinated girls in Ethiopia to over 13 million | WHO | Regional Office for Africa [Internet]. 2025. https:\/\/www.afro.who.int\/countries\/ethiopia\/news\/human-papillomavirus-hpv-single-dose-schedule-elevated-total-number-vaccinated-girls-ethiopia-over. Available from. [cited 2025 Jan 23]."},{"key":"14336_CR38","unstructured":"Over 5 million girls in Tanzania to receive HPV vaccine to combat cervical cancer | WHO | Regional Office for Africa [Internet]. 2024. https:\/\/www.afro.who.int\/countries\/united-republic-of-tanzania\/news\/over-5-million-girls-tanzania-receive-hpv-vaccine-combat-cervical-cancer. cited 2025 Feb 3]. Available from."},{"key":"14336_CR39","unstructured":"World Health Organization. Human papillomavirus vaccination in Ethiopia protects over 6.3 million girls from cervical cancer | WHO | Regional Office for Africa [Internet]. 2024. https:\/\/www.afro.who.int\/countries\/ethiopia\/news\/human-papillomavirus-vaccination-ethiopia-protects-over-63-million-girls-cervical-cancer. Available from. [cited 2025 Jan 23]."},{"key":"14336_CR40","unstructured":"Adeyanju GC, Essoh TA, Sidibe AR, Kyesi F, Aina M. Human papillomavirus vaccination acceleration and introduction in sub-Saharan Africa: a multi-country cohort analysis. Nato Adv Sci Inst Se [Internet]. 2024, May, 1;12(5). Available from: https:\/\/research.ebsco.com\/linkprocessor\/plink?id=8020f30e-bddd-3c62-9c92-6c1b735fe12d."},{"key":"14336_CR41","unstructured":"Africa immunization advisory group urges single-dose HPV vaccine adoption to advance vaccination efforts | WHO | Regional Office for Africa [Internet]. 2025. https:\/\/www.afro.who.int\/news\/africa-immunization-advisory-group-urges-single-dose-hpv-vaccine-adoption-advance-vaccination. Available from. [cited 2025 Jan 31]."},{"key":"14336_CR42","doi-asserted-by":"crossref","unstructured":"Bolio A, Waheed D, Mugo N, Garland N, Wanyoike SM, Njambe Tondo Opute S, et al. Overview of CHIC symposia series: summary of Africa and South Asia symposia. Vaccine. 2024, July, 11;42:S9\u201315.","DOI":"10.1016\/j.vaccine.2023.10.063"},{"key":"14336_CR43","unstructured":"Jsi_decision making considerations and drivers of country level adoption or switch to a single dose HPV vaccination Schedule__A global Assessment_Technical report."},{"key":"14336_CR44","unstructured":"E-NITAG - single dose of HPV vaccination 09Mar2023_Final.Pdf [Internet]. Available from. https:\/\/www.nitag-resource.org\/sites\/default\/files\/2023-06\/E-NITAG%20-%20%20Single%20Dose%20of%20HPV%20Vaccination%2009Mar2023_Final.pdf. [cited 2025 Jan 23]."},{"key":"14336_CR45","unstructured":"Ra K. An assessment of the readiness for introduction of the HPV vaccine in Uganda. Afr J Reprod Health. 2008;12(3)."},{"issue":"1","key":"14336_CR46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1750-9378-7-24","volume":"7","author":"C Banura","year":"2012","unstructured":"Banura C, Mirembe FM, Katahoire AR, Namujju PB, Mbidde EK. Universal routine HPV vaccination for young girls in Uganda: a review of opportunities and potential obstacles. Infect Agent Cancer. 2012, Dec;7(1):24.","journal-title":"Infect Agent Cancer"},{"issue":"12","key":"14336_CR47","doi-asserted-by":"publisher","first-page":"707","DOI":"10.15171\/ijhpm.2017.37","volume":"6","author":"L Wallace","year":"2017","unstructured":"Wallace L, Kapirir L. How are New vaccines prioritized in low-income countries? A case study of human papilloma virus vaccine and pneumococcal conjugate vaccine in Uganda. Int J Health Policy Manag. 2017, Apr, 8;6(12):707\u201320.","journal-title":"Int J Health Policy Manag"},{"key":"14336_CR48","unstructured":"What could a single-dose HPV vaccine schedule mean for Uganda? [Internet]. Available from. https:\/\/www.path.org\/our-impact\/resources\/what-could-single-dose-hpv-vaccine-schedule-mean-uganda\/. [cited 2025 Jan 29]."},{"issue":"6","key":"14336_CR49","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.3390\/cancers12061520","volume":"12","author":"DW Njuguna","year":"2020","unstructured":"Njuguna DW, Mahrouseh N, Onisoyonivosekume D, Varga O. National policies to prevent and manage cervical cancer in East African countries: a policy mapping analysis. Cancers. 2020, June, 10;12(6):1520.","journal-title":"Cancers"},{"key":"14336_CR50","unstructured":"John Snow, Inc. The vital role of communities - experience from human papillomavirus vaccination."},{"key":"14336_CR51","unstructured":"World Cancer Research Fund. World cancer Research Fund. Cervical cancer statistics. Available from. https:\/\/www.wcrf.org\/preventing-cancer\/cancer-statistics\/cervical-cancer-statistics\/. [cited 2025 Feb 5]."},{"key":"14336_CR52","doi-asserted-by":"crossref","unstructured":"Guillaume D, Waheed D, Schleiff N, Muralidharan M, Vorsters KK, Limaye A, et al. Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries. PLoS One. 2024, Jan, 16;19(1):e0291990.","DOI":"10.1371\/journal.pone.0291990"},{"key":"14336_CR53","doi-asserted-by":"crossref","unstructured":"Uwizihiwe JP. 40th anniversary of introduction of expanded immunization program (EPI): a literature review of introduction of New vaccines for routine childhood immunization in sub-Saharan Africa. Int J Vaccines Vaccin [Internet]. 2015, July, 2;1(1). Available from: https:\/\/medcraveonline.com\/IJVV\/40th-anniversary-of-introduction-of-expanded-immunization-program-epi-a-literature-review-of-introduction-of-new-vaccines-for-routine-childhood-immunization-in-sub-saharan-africa.html. cited 2025 Jan 14.","DOI":"10.15406\/ijvv.2015.01.00004"},{"key":"14336_CR54","doi-asserted-by":"crossref","unstructured":"Burchett HED, Mounier-Jack S, Griffiths UK, Biellik R, Ongolo-Zogo P, Chavez E, et al. New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries. Health Policy Plan. 2012, May;27Suppl, 2: ii5\u201316.","DOI":"10.1093\/heapol\/czs035"},{"key":"14336_CR55","doi-asserted-by":"crossref","unstructured":"Mhazo AT, Maponga CC. Beyond political will: unpacking the drivers of (non) health reforms in sub-saharan Africa. BMJ Glob Health [Internet]. 2022, Dec, 1;7(12). Available from: https:\/\/gh.bmj.com\/content\/7\/12\/e010228. cited 2025 Feb 11.","DOI":"10.1136\/bmjgh-2022-010228"},{"issue":"4","key":"14336_CR56","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/175797590200900401","volume":"9","author":"MR Reich","year":"2002","unstructured":"Reich MR. The politics of Reforming Health policies. Promot Educ. 2002, Dec, 1;9(4):138\u201342.","journal-title":"Promot Educ"},{"issue":"1","key":"14336_CR57","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12982-024-00321-8","volume":"21","author":"AA Adamu","year":"2024","unstructured":"Adamu AA, Ndiaye S, Jalo RI, Karamagi H, Ngwakum P, Ndwandwe D, et al. Enhancing vaccine delivery in Africa with implementation science. Discov Public Health. 2024, Nov, 12;21(1):190.","journal-title":"Discov Public Health"},{"key":"14336_CR58","doi-asserted-by":"crossref","unstructured":"Roy S, Wysong MD, Rosser EN, Sheth I, Geddes C, Limaye RJ, et al. Pathways and processes to adopting or switching to a single-dose HPV vaccination schedule in low- and middle-income countries: a qualitative study. PLoS Glob Public Health. 2025, Feb, 5;5(2):e0004245.","DOI":"10.1371\/journal.pgph.0004245"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-14336-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14336-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14336-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:14:51Z","timestamp":1777428891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-026-14336-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14336"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-14336-1","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable to the rapid review presented in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable to the rapid review presented in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"G.U. reports research funding from the Sub-Saharan Africa L\u2019Or\u00e9al-UNESCO for Women in Science Young Talent program outside this study. N.R.M. reports research funding from the Merck Investigator Studies Program, outside this study. R.V.B. reports that Regeneron Pharmaceuticals provided abstract and manuscript writing support outside this study. All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"608"}}